289 related articles for article (PubMed ID: 25613306)
1. Thrombolysis in pediatric stroke study.
Rivkin MJ; deVeber G; Ichord RN; Kirton A; Chan AK; Hovinga CA; Gill JC; Szabo A; Hill MD; Scholz K; Amlie-Lefond C
Stroke; 2015 Mar; 46(3):880-5. PubMed ID: 25613306
[No Abstract] [Full Text] [Related]
2. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
4. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
Wechsler LR
Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
[No Abstract] [Full Text] [Related]
5. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
Schellinger PD; Köhrmann M
Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
[No Abstract] [Full Text] [Related]
6. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis, community hospitals, and primary stroke center.
Jeng JS
Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
[No Abstract] [Full Text] [Related]
9. Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?
Selim MH; Molina CA
Stroke; 2014 Mar; 45(3):916-7. PubMed ID: 24526059
[No Abstract] [Full Text] [Related]
10. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
[TBL] [Abstract][Full Text] [Related]
11. Relationships between age, other predictive variables, and the 90-day functional outcome after intravenous thrombolysis for acute ischemic stroke.
Gunathilake R; Krishnamurthy V; Oldmeadow C; Kerr E; Padmakumar C; Attia J; Parsons M; Levi C
Int J Stroke; 2014 Oct; 9(7):E36-7. PubMed ID: 25231586
[No Abstract] [Full Text] [Related]
12. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
Moonis M
Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
[No Abstract] [Full Text] [Related]
13. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation.
Montaner J
Stroke; 2008 Jan; 39(1):e6. PubMed ID: 18048844
[No Abstract] [Full Text] [Related]
14. Plasminogen activation and thrombolysis for ischemic stroke.
Medcalf RL; Davis SM
Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
[TBL] [Abstract][Full Text] [Related]
15. Successful intravenous thrombolysis for acute stroke in a child.
Ortiz GA; Koch S; Wallace DM; Lopez-Alberola R
J Child Neurol; 2007 Jun; 22(6):749-52. PubMed ID: 17641263
[TBL] [Abstract][Full Text] [Related]
16. Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: the Bergen stroke study.
Naess H; Idicula T; Lagallo N; Brogger J; Waje-Andreassen U; Thomassen L
Acta Neurol Scand; 2010 Dec; 122(6):414-7. PubMed ID: 20199522
[TBL] [Abstract][Full Text] [Related]
17. The prospects and predicaments of intravenous rt-PA in childhood ischemic stroke.
Behrouz R
Expert Rev Neurother; 2014 Mar; 14(3):255-9. PubMed ID: 24491039
[TBL] [Abstract][Full Text] [Related]
18. First thrombolysis in acute stroke with tenecteplase in Congo.
Ossou-Nguiet PM; Otiobanda GF; Ellenga-Mbolla BF; Ikama MS; Ondze Kafata LI; Bandzouzi-Ndamba B
Int J Stroke; 2013 Oct; 8(7):E47. PubMed ID: 24024923
[No Abstract] [Full Text] [Related]
19. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial.
Amlie-Lefond C; Chan AK; Kirton A; deVeber G; Hovinga CA; Ichord R; Stephens D; Zaidat OO;
Neuroepidemiology; 2009; 32(4):279-86. PubMed ID: 19223687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
